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Extremely Skewed X-Chromosome Inactivation Is
Increased in Women with Recurrent Spontaneous
Abortion
To the Editor:
Recurrent spontaneous abortion (RSA), defined as three
or more consecutive losses at 20 wk gestation (Stirrat
1990), affects 1%–2% of couples trying to have a family
(Stray-Pedersen and Lorentzen-Styr 1979; Roman
1984). Although spontaneous abortion occurs quite fre-
quently in humans, affecting ∼15% of all clinically rec-
ognized pregnancies (Warburton and Fraser 1964; Ed-
monds et al. 1982; Wilcox et al. 1988), the observed
rate of RSA is much higher than the expected rate of
0.3% due to chance alone. This suggests the presence
of factors that may predispose particular couples to mul-
tiple pregnancy losses. Nearly 60% of RSA cases can be
potentially explained by identifiable autoimmune, en-
docrine, anatomical, or infectious factors or by struc-
tural chromosome rearrangements in one partner (Ste-
phenson 1996). However, 140% of RSA is still
unexplained. We suggest that a significant proportion of
the unexplained cases of RSA may be caused by a genetic
mutation or chromosomal abnormality that would not
be discovered by routine investigation.
X-chromosome inactivation (XCI) is the process
whereby one of the two X chromosomes present in each
cell of female mammals is inactivated during early em-
bryogenesis, to achieve dosage compensation with males
(Lyon 1961). Generally, in a given cell type in humans,
the maternal X chromosome is inactivated approxi-
mately equally as often as the paternal X chromosome
(Belmont 1996). However, extremely skewed XCI, de-
fined in this letter as 190% inactivation of one allele, is
observed in ∼2% of newborns and ∼4.5% of 28–32-
year-old women (Busque et al. 1996). This extremely
skewed XCI pattern may be due to a number of possible
causes: (1) chance; (2) a mutation in the XIST gene that
is found on the X chromosome and is thought to be
critical in the inactivation process (Plenge et al. 1997);
(3) selection against cells with a growth disadvantage
because of a deletion or mutation on one of the X chro-
mosomes (Pegoraro et al. 1997) or to an X-autosome
translocation (Gaal and Laszlo 1977); and (4) a reduc-
tion in the fetal precursor-cell pool size, as has been
suggested to occur in twinning (Bamforth et al. 1996;
Goodship et al. 1996). Trisomy mosaicism has also re-
cently been shown to be associated with extremely
skewed XCI (Lau et al. 1997). Extremely skewed XCI
(190% inactivation of one allele) was found in the ma-
jority (11 of 18) of prenatally detected mosaic cases
when the trisomic cell line was of meiotic origin and
absent from most fetal tissues (Lau et al. 1997; W.P.
Robinson and M.S. Pen˜ahererra, unpublished data).
Skewing is hypothesized to result from a reduction in
the number of embryonic precursor cells, because of se-
lection against the trisomic cells shortly after XCI.
At least three causes of skewed XCI are expected to
be associated with an increased risk of spontaneous
abortion: (1) some deletions or mutations on the X chro-
mosome may be lethal to male fetuses carrying the ab-
normal X chromosome (Pegoraro et al. 1997); (2)
X-autosome translocations can lead to RSA, because
some gametes may be deleted and/or duplicated for por-
tions of each chromosome that are involved in the re-
arrangement (Byrne and Ward 1994); and (3) trisomy
mosaicism may also be associated with RSA if the germ-
line is affected, since recurrent aneuploidy may result
(Kohn and Shohat 1987; Gersdorf et al. 1990; Satge et
al. 1996). Although it is impossible to determine how
often the germline is mosaic in individuals with a normal
phenotype and blood karyotype, one case was reported
in which trisomy 16 was found in placenta and oocytes
but in no other fetal tissue (Stavropoulos et al. 1998).
To evaluate the degree to which mosaicism or other ge-
netic factors associated with extremely skewed XCI may
contribute to RSA, we screened women with RSA in
order to determine their XCI status and compared them
with controls of similar age.
Patients were ascertained through the Recurrent Preg-
nancy Loss Clinic at British Columbia’s Women’s Hos-
pital and Health Centre. Between September of 1997
and December of 1998, all new patients with a history
of RSA who were seen by the one of the authors (M.D.S.)
were offered participation in this study. RSA was defined
as three or more consecutive pregnancy losses prior to
20 wk gestation, with each pregnancy documented by
a positive result on serum or urinary hCG, ultrasound,
or pathology. Ethics approval was obtained from the
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Table 1
Proportion of Females with RSA Who Showed Extremely
Skewed XCI Compared with Control Females
GROUP
NO. (%) OBSERVED WITH
!90% Skewing 190% Skewing
Females with RSA 62 (82) 14 (18)
Control females 105 (95) 6 (5)
NOTE.—For comparison by x2, P ! .001.
University of British Columbia Clinical Research Ethics
Board, and the consent form was thoroughly reviewed
with each patient. A single tube of peripheral blood was
collected from consenting women, and DNA was ex-
tracted by use of a standard protocol. Every effort was
made to collect these blood samples when samples for
other standard blood work were being collected, ac-
cording to the RSA protocol of Stephenson (1996). Con-
trols were mothers who had donated blood previously,
each having had at least one full-term pregnancy.
The mean number of consecutive spontaneous abor-
tions per patient was 4.1, with a range of 3–11. Patients’
ages were 19–45 years, with a mean of 33.6 years. For
the control group, the age at which the blood was drawn
was available for 86 of the 111 individuals informative
at the androgen-receptor (AR) locus; the controls’ ages
were 20–49 years, with a mean age of 35.0 years. Results
of karyotype analysis using standard Giemsa banding at
550-band resolution, in patients with RSA, their repro-
ductive partners, and prior spontaneous abortions were
taken from patients’ charts; a total of 49 aborted preg-
nancies from patients with RSA who were informative
for XCI status underwent karyotype analysis.
The degree of skewed XCI was estimated by an assay
based on a methylation-sensitive HpaII restriction site
located near the human AR gene. This site is known to
be methylated on the inactive X chromosome and to be
unmethylated on the active X chromosome (Allen et al.
1992). When HpaII was used to digest the genomic DNA
prior to PCR, the AR allele was amplified only from the
inactive X chromosome, since the sequence to be am-
plified on the active X chromosome was cleaved by the
restriction enzyme. A trinucleotide CAG-repeat poly-
morphism located within the amplified region was used
to distinguish between the two X chromosomes. For
each patient, two PCR reactions were performed—one
with genomic DNA digested with HpaII and one without
HpaII. The second reaction served as an internal control
to establish a baseline level of amplification of each al-
lele, specific to the individual. This measure corrected
for any preferential amplification of one allele over the
other, in a given patient. Genomic DNA from males was
used as a digestion control, since their X chromosome
is always active (unmethylated) and therefore should
have been completely digested by HpaII and should have
yielded no amplification product. Products were sepa-
rated by PAGE and were visualized by silver staining.
Quantification of the resulting bands was performed as
detailed elsewhere (Lau et al. 1997). The analysis was
repeated for any patient in whom skewing was 170%,
in order to verify the result. Thus, the degree of skewing
reported in these cases was an average of two or three
independent tests; the mean difference between two es-
timates of skewing for the same patient was four per-
centage points.
XCI status was informative in 76 of the 98 patients
with RSA and in 111 of the 137 female controls. This
frequency may be less than that in other reports because
some heterozygous cases were considered to be unin-
formative if the two bands were too close to resolve
adequately for densitometric analysis. Extremely skewed
XCI, defined as 190% amplification of one allele, was
found in 14 (18%) of the 76 informative females with
RSA and in just 6 (5%) of the 111 controls ( ;P ! .001
x2 test) (see table 1). The mean rate of skewing in the
control group was similar to the 4.5% rate of skewing
observed by Busque et al. (1996) in women 28–32 years
of age. This rate was not significantly altered if controls
for whom no age data were available were excluded.
These results show that factors associated with ex-
tremely skewed XCI account for a significant proportion
(i.e., as much as 18%) of couples with RSA. Similar
results have been reported, by Lanasa et al. (1999), for
women who have experienced two or more spontaneous
abortions. What is the explanation for extreme skewing
in these patients with RSA? A pattern of extremely
skewed XCI is commonly seen in females who carry
balanced translocations involving one X chromosome
and an autosome. The normal X chromosome is usually
preferentially inactivated, presumably to maintain a bal-
anced chromosomal complement in each cell (Gaal and
Laszlo 1977). Theoretically, X-chromosome rearrange-
ments could also lead to recurrent pregnancy loss. How-
ever, in a study that reported karyotype results in 1,142
couples with recurrent abortion there was not a single
rearrangement involving the X chromosome (Portnoi et
al. 1988). Thus, this is too rare a finding to account for
the significant number of patients with RSA whom we
observed to have extremely skewed XCI. Furthermore,
in our study, all 14 of the patients with RSA who had
extreme skewing had normal results on karyotype anal-
ysis—that is, 46,XX (see table 2).
Extremely skewed XCI may also result from a mu-
tation on one of the two X chromosomes because of
selective advantage of those cells that have the normal
X chromosome active. In such cases, any male conceptus
inheriting the abnormal X chromosome would most
likely be aborted, because of the presence of only the
defective copy of the locus in question. One such family
has been reported in which 100% of the females exhib-
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Table 2
Karyotype Data on Female Patients with
RSA and on Their Male Reproductive
Partners
Gender and Karyotype No.
Females:
46,XXa 86
46,XX,t(2;12)(q13;q24.31) 1
46,XX,t(8;12)(q22;q22) 1
46,XX,inv(2)(p11.2q13) 1
46,XX/45,Xb 1
NA 8
Total 98
Males:
46,XY 81
NA 17
Total 98
a All 14 patients with RSA who had ex-
tremely skewed XCI also had a 46,XX
karyotype.
b A 45,X karyotype was found in 4/100
lymphocytes, and further examination
showed a 46,XX karyotype in 30/30 skin fi-
broblast cells.
Table 3
Karyotypes of Spontaneous Abortions among Female Patients with
RSA Who Have Extremely Skewed XCI, versus Those Who Do Not
Have Such Skewing
TYPE OF
ABORTUS
KARYOTYPED
NO. OF ABORTUSES FROM PATIENTS WHO HAVE
!90% Skewing 190% Skewing
46,XY 14 1
46,XX 11 1
Aneuploid 15a 7a
Total 40 9
a (by Fisher’s exact test comparing proportion of abnormalP = .03
karyotypes in the two groups).
iting extremely skewed XCI showed the presence of an
X chromosome with an inherited deletion (Pegoraro et
al. 1997). The women in this family had a spontaneous-
abortion rate more than twice that in their female rel-
atives who did not have the deletion or skewing. They
also had a greater proportion of live-born females than
of live-born males. There is currently no efficient method
that can screen for mutations on the X chromosome that
affect viability. However, it would be expected that, if
this were the cause of RSA in our group of patients with
extremely skewed XCI, then a high rate of 46,XY kar-
yotypes should be seen among their spontaneous abor-
tions. Of the karyotyped spontaneous-abortion speci-
mens that were euploid, 1 of the 2 abortuses from
patients with skewing was male, compared with 14
males among the 25 normal abortuses from patients with
RSA and without skewing (table 3).
It should be noted that, although the frequency of
pregnancy loss would be higher in carriers of an X-
chromosome mutation or deletion than in the general
population, in theory only 25% of the conceptuses (i.e.,
one-half of the males) would be at risk of being aborted
because of the mutation; this is because all of the females
and half of the males should be protected from the mu-
tation, by the presence of the normal X chromosome. If
it is assumed that the population rate of abortion due
to independent causes is 15%, then the joint probability
of pregnancy loss would be ∼36%. Thus, only a small
number (i.e., ∼5%) of women with such an X-chro-
mosome mutation might be expected to have three or
more consecutive spontaneous abortions and no live
births. Thus, an X-chromosome mutation might be rel-
atively more common among women with either only a
few losses or several losses combined with some live
births than it is among women who experience a larger
number of losses and no successful full-term pregnancies.
It is therefore interesting to note that the mean number
of spontaneous abortions (4.1) in the 14 patients who
had skewed XCI was equal to that of the entire group
with RSA.
Finally, a factor that may be associated with both ex-
tremely skewed XCI and RSA is aneuploidy mosaicism.
Although aneuploidy is the leading cause of random
spontaneous abortion, accounting for ∼50% of kary-
otyped losses (Boue et al. 1975; Hassold and Jacobs
1984), it is difficult to evaluate whether recurrence of
the same aneuploidy occurs more often than would be
expected by chance, since karyotype information on
each loss is lacking in most RSA cases. Nonetheless,
many cases of gonadal mosaicism for a trisomy have
been reported, many of which are ascertained by the
multiple recurrence of Down syndrome (Kohn and Sho-
hat 1987; Nielsen et al. 1988; Gersdorf et al. 1990; Sachs
et al. 1990; Pangalos et al. 1992; Tseng et al. 1994; Satge
et al. 1996), and mosaicism is found in the lymphocytes
of one of the two parents in 4% of families with Down
syndrome (Uchida and Freeman 1985). However, even
if germline mosaicism were a cause of RSA, we would
not necessarily expect the same trisomy to recur, since
it has been shown that the presence of an unpaired chro-
mosome in mouse oocytes can cause both disruption of
meiosis and missegregation of other chromosomes (Hunt
et al. 1995). There is also evidence from rare cases of
fertile 45,X women that the same effect occurs in hu-
mans (Warburton 1989). In our study, seven of nine
spontaneous-abortion specimens from the group of
women with extremely skewed XCI were found to be
aneuploid, whereas, among the women with nonskewed
XCI, just 15 (27%) of 40 spontaneous-abortion speci-
mens were aneuploid ( ; see table 3). AlthoughP = .03
both skewed XCI and aneuploidy increase with maternal
age (Hassold and Jacobs 1984; Busque et al. 1996), the
mean age of the patients with extremely skewed XCI
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was lower (32.4 years) than that of the group without
skewing (33.9 years). Thus, age cannot explain the
higher rate of aneuploidy in the spontaneous-abortion
specimens from patients with extremely skewed XCI.
It is estimated that 1%–2% of first-trimester preg-
nancies assessed by chorionic-villus sampling are mosaic
(Vejerslev and Mikkelsen 1989). Although the abnormal
cell line is often assumed to be confined to the placenta,
this is difficult to prove. Even when mosaicism is found
in amniotic fluid, the aneuploidy is frequently absent
from fetal/newborn blood (Hsu et al. 1997), and trisomy
mosaicism for most chromosomes is unlikely to be de-
tected by routine blood karyotyping. Although analysis
of skin fibroblasts may detect a greater proportion of
mosaic cases, it is still possible for trisomic cells to be
found in oocytes even when no other fetal tissues are
affected (Stavropoulos et al. 1998). Alternatively, we can
look at indirect indicators, such as skewed XCI, to pro-
vide clues as to whether an individual may be the prod-
uct of a pregnancy associated with mosaicism.
Pregnancy loss is a devastating issue for many couples,
and identification of an etiology is very important for
counseling couples with RSA as to their treatment op-
tions. Clearly, genetic factors associated with extremely
skewed XCI are important in at least some patients with
RSA and, most likely, involve either an X-linked mu-
tation or germline mosaicism. Further review of the med-
ical histories and pedigrees may provide clues as to
which etiology is involved in a particular case. A larger
epidemiological study documenting the outcome of all
pregnancies and including karyotype data from the
spontaneous abortions is also necessary to clarify the
mechanism involved and, subsequently, to improve
counseling of patients with RSA, in regard to future
pregnancy outcomes.
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Demonstration of the Recurrence of Marfan-like
Skeletal and Cardiovascular Manifestations Due to
Germline Mosaicism for an FBN1 Mutation
To the Editor:
Marfan syndrome (MFS [MIM 154700]) is a dominantly
inherited disease of connective tissue. Cardinal manifes-
tations involve the eye (lens dislocation and myopia),
skeleton (dolichostenomelia, arachnodactyly, anterior
chest deformity, spinal curvature, and joint laxity) and
cardiovascular system (aortic root dilation and dissec-
tion, mitral valve prolapse, and mitral and aortic valve
regurgitation). Striae distensae and inguinal hernia are
frequent findings in the integument, and pneumothorax
and dural ectasia occur in some patients (Pyeritz and
McKusick 1979; First International Symposium on the
Marfan Syndrome 1989). If untreated, the syndrome
shortens life expectancy mainly because of cardiovas-
cular complications. The disorder is characterized by
considerable variation in the distribution and severity of
organ system involvement between families, leading to
the definition of diagnostic criteria listed first in the Ber-
lin nosology (Beighton et al. 1988) and subsequently
revised in the Ghent nosology (de Paepe et al. 1996). In
1986, Sakai and colleagues identified a 350-kD glyco-
protein called “fibrillin,” which represents the major
structural component of connective tissue microfibrils.
By using an anti-fibrillin antibody, Godfrey, Hollister,
and their colleagues demonstrated a reduction of mi-
crofibrils in immunofluorescence studies of cultured der-
mal fibroblasts in patients with MFS (Godfrey et al.
1990; Hollister et al. 1990). Subsequent studies of fi-
brillin synthesis, secretion, and incorporation into the
extracellular matrix showed abnormalities in most but
not all MFS fibroblast strains (Milewicz et al 1992; Col-
lod et al. 1994). Finally, mutations in the FBN1 gene,
encoding fibrillin, have been demonstrated to result in
MFS or associated phenotypes (Dietz et al. 1991; Hay-
ward et al. 1994; Kainulainen et al. 1994; Lonnqvist et
al. 1994; Sood et al. 1996). The FBN1 gene is ∼200 kb
in size, with a coding sequence fragmented into 65 exons
(Corson et al. 1993; Pereira et al. 1993; Biery et al. 1999)
located on chromosome 15q21.1 (Magenis et al. 1991).
